Nilocare 150mg Capsule
Marketer
Archerchem Healthcare Pvt Ltd
Salt Composition
Nilotinib (150mg)
Overview Nilocare 150mg Capsule
Nilocard 150mg capsules treat chronic myeloid leukemia (CML), specifically in patients unresponsive to or intolerant of other leukemia therapies. Administer on an empty stomach, consistently at the same time daily for optimal efficacy. Dosage and frequency are determined by your physician, based on your condition and may be adjusted. Adhere strictly to prescribed instructions; incorrect usage or overdosage can cause severe adverse reactions. Therapeutic benefits may take weeks or months to manifest; discontinue only under medical supervision. Common side effects include headache, nausea, abdominal pain, and rash. Severe diarrhea necessitates medical attention or increased fluid intake. This medication can lower blood cell counts (red and white), increasing infection risk. Regular blood tests monitoring blood cell levels, along with heart, liver, uric acid, blood sugar, and lipid profiles, are essential. Inform your doctor of pre-existing heart, liver, or kidney disease, or any concurrent infection treatments before commencing. Interaction with other medications is possible; disclose all current medications to your healthcare provider. Avoid pregnancy during treatment; effective contraception is crucial for both partners.
Uses of Nilocare 150mg Capsule
Chronic myelogenous leukemia, a type of blood malignancy
Major Benefits of Nilocare 150mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Consume Nilocare 150mg Capsules on an empty stomach.
Common Side effects of Nilocare 150mg Capsule:
- Headache
- Nausea
- Abdominal pain
- Rash
- Itching
- Hair loss
- Muscle pain
- Fatigue
How to use Nilocare 150mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Nilocare 150mg Capsules should be administered on an empty stomach.
How Nilocare 150mg Capsule works:
Cancer treatment Nilocare, in its 150mg capsule form, inhibits the activity of a rogue protein responsible for cancer cell proliferation, thus hindering or slowing cancerous growth.
SAFETY ADVICE
AlcoholSAFE
Nilocare 150mg Capsule may be taken with alcohol without adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Use of Nilocare 150mg capsules is contraindicated during pregnancy due to established fetal risk. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is recommended.
Breast feedingUNSAFE
Breastfeeding mothers should avoid Nilocare 150mg Capsules. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Taking a Nilocare 150mg capsule might cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these side effects.
KidneySAFE IF PRESCRIBED
Nilocare 150mg capsules appear to pose minimal risk for individuals with kidney impairment. Existing evidence indicates dose modification of Nilocare 150mg capsules may be unnecessary in such cases. However, physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should exercise caution when using Nilocare 150mg capsules. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Nilocare 150mg Capsule :
Omit any missed Nilocare 150mg Capsule and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Nilocare 150mg Capsule
| Label | Value |
|---|---|
| Chemical Type | Pyrimidine Aminoderivative |
| Developing Habits | No. |
| Type of Therapy | Cancer Treatments |
| Action Class | TKIs |



